BioNTech Results Presentation Deck slide image

BioNTech Results Presentation Deck

BNT162 Manufacturing Update Clinical supply BioNTech to manufacture all drug substance for clinical supply at its GMP manufacturing facilities in Idar-Oberstein and Mainz (both in Germany, partially 24/7 manufacturing) Global pandemic and commercial supply capacities Joint establishment of pandemic supply capacities at many network sites BioNTech: At Idar-Oberstein and Mainz facilities in Germany Pfizer: At least at three U.S. sites (Massachusetts, Michigan, Missouri) and at Puurs facility (Belgium) BioN Tech and Pfizer working closely together (joint teams) on scale-up, supply chain and network planning ● ● Drug product supply initially supported by BioNTech's formulation partner Polymun, with Pfizer and BioNTech ramping up own capacity 8 ● ● BIONTECH
View entire presentation